Trial intelligence / Profile preview

Effect of Neural Constraints on Movement in Stroke

NCT06666673Phase 1Recruiting

Sponsor
Northwestern University
Start
Aug 2024
Primary completion
Jun 2029
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of tizanidine in stroke (2 arms), sponsored by Northwestern University. Primary endpoints: Brace Height, Cortico-muscular-coherence in beta band and 2 more. Started Aug 2024; status: recruiting.

02

Drugs

tizanidine
03

Conditions

stroke

Beyond the preview

Go deeper on NCT06666673.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06666673.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call